SPIMACO Pharmaceutical company announced today on tadawul restructuring its operations in the Algerian market performed through its totally owned subsidiary; SPIMACO Algeria; as of 1/1/2013.
SPIMACO Algeria is in the business of marketing and distributing SPIMACO’s pharmaceutical products in Algeria.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}